NCT00002081View on ClinicalTrials.gov

Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (1)

021810003

ddC Coordinating Ctr, Wellesley Hills

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00002081 - Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease | Biotech Hunter | Biotech Hunter